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Abstract
The NK homeodomain factor Tinman is a crucial regulator of early mesoderm patterning and, together with the GATA factor
Pannier and the Dorsocross T-box factors, serves as one of the key cardiogenic factors during specification and
differentiation of heart cells. Although the basic framework of regulatory interactions driving heart development has been
worked out, only about a dozen genes involved in heart development have been designated as direct Tinman target genes
to date, and detailed information about the functional architectures of their cardiac enhancers is lacking. We have used
immunoprecipitation of chromatin (ChIP) from embryos at two different stages of early cardiogenesis to obtain a global
overview of the sequences bound by Tinman in vivo and their linked genes. Our data from the analysis of ,50 sequences
with high Tinman occupancy show that the majority of such sequences act as enhancers in various mesodermal tissues in
which Tinman is active. All of the dorsal mesodermal and cardiac enhancers, but not some of the others, require tinman
function. The cardiac enhancers feature diverse arrangements of binding motifs for Tinman, Pannier, and Dorsocross. By
employing these cardiac and non-cardiac enhancers in machine learning approaches, we identify a novel motif, termed CEE,
as a classifier for cardiac enhancers. In vivo assays for the requirement of the binding motifs of Tinman, Pannier, and
Dorsocross, as well as the CEE motifs in a set of cardiac enhancers, show that the Tinman sites are essential in all but one of
the tested enhancers; although on occasion they can be functionally redundant with Dorsocross sites. The enhancers differ
widely with respect to their requirement for Pannier, Dorsocross, and CEE sites, which we ascribe to their different position
in the regulatory circuitry, their distinct temporal and spatial activities during cardiogenesis, and functional redundancies
among different factor binding sites.
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Introduction
Early cardiogenesis in Drosophila relies on a regulatory network
of evolutionarily conserved transcription factors and closely
integrated signalling events. The key cardiogenic transcription
factors include the NK homeodomain factor Tinman (Tin), the
GATA factor Pannier (Pnr), and the Dorsocross T-box factors
(Doc1, -2 and -3). Loss of function of either of these factors results
in a complete failure of heart formation (reviewed in [1], [2]). In
vertebrates, closely related factors such as the NK homeodomain
factor Nkx2-5, GATA4, -5, and -6, and Tbx2, -3, and -5 are
likewise known to play prominent roles during early development
of the normal heart and in congenital heart disease (reviewed in
[3]). In Drosophila, tinman is active as the earliest among these three
types of cardiogenic genes as it is initially activated during
gastrulation by the bHLH factor Twist in almost the entire
mesoderm [4], [5]. After gastrulation and mesoderm spreading,
Tin protein is then required in conjunction with Dpp signals from
the dorsal ectoderm for inducing the expression of pnr and
maintaining the expression of its own gene, tin, in the dorsal
mesoderm [6], [7]. During the same time, the expression of the
Doc genes is induced by combinatorial Dpp and Wg signals,
independently of tin and pnr, in segmentally-repeated areas within
the dorsal mesoderm [8]. Within these areas, the three cardiogenic
genes then maintain each others’ expression via cross-regulatory
interactions in the presence of perduring Dpp signals. In these cells
of the cardiogenic mesoderm, each of the three classes of
cardiogenic factors is critically required for the induction of
cardiomyocyte progenitors (also known as cardioblasts). In the
developing heart, the expression of tin and Doc, but not pnr, is
maintained in cardioblasts and, in the case of tin, also in a subset of
non-contractile pericardial cells. Unlike during the earlier stages,
tin and Doc are expressed in mutually-exclusive subsets of
cardioblasts within the heart, which involves cross-repressive
interactions [9]. tin is expressed in four out of a total of six bilateral
pairs of cardioblasts of the heart in each segment and is needed for
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specifying them as ‘‘working’’ cardiomyocytes, whereas Doc is
expressed in the remaining two pairs and regulates their
differentiation into inflow valves (ostia).
In accordance with its early and more widespread expres-
sion, first in almost the entire mesoderm and then in the whole
dorsal mesoderm, tin fulfills functions in addition to cardiogen-
esis during mesoderm patterning and mesodermal tissue
development (reviewed in [10]). In the dorsal mesoderm, tin
is required for the formation of all somatic muscle founder cells
and their corresponding muscles. Moreover, in the dorsal
segmental areas between the segmental cardiac primordia tin is
essential for the formation of the primordia of the trunk
visceral mesoderm. In ventral-lateral regions of the somatic
mesoderm tin is also required for the formation of muscle
founders, albeit only for a specific subset of them. Lastly, in
mesodermal areas along the ventral midline, tin is required for
the formation of glia-like cells, termed Dorsal Median cells.
Importantly, during all these events including cardiogenesis, tin
has an obligatory requirement for additional, spatially-
restricted factors and signalling effectors to fulfill its functions.
This requirement is most evident from the observations that, in
the normal situation, defined responses to tin only occur in
specific subareas within Tin-expressing domains, and that
forced uniform expression of tin in the mesoderm produces
only minor alterations during mesodermal tissue development
[11]. The molecular basis for these combinatorial and
synergistic requirements has been clarified most extensively
for the activation of the homeobox genes even-skipped (eve) in
specific dorsal muscle founders as well as pericardial progen-
itors and bagpipe (bap) in the trunk visceral mesoderm
primordia. Both eve and bap are direct targets of tin that
contain essential Tin binding sites within their respective
mesodermal enhancers. In addition, however, the eve enhancer
(MHE/EME) requires sites for the pan-mesodermal regulator
Twist, Smad binding sites targeted by Dpp, TCF/Pan sites that
mediate both derepression and activation in cells receiving Wg
signals, and Ets domain binding motifs likely mediating inputs
from receptor tyrosine kinases [12]–[14]. Likewise, the bap
enhancer additionally requires Smad sites for its activation (in
cells receiving Dpp but not Wg signals) and sites for the
forkhead domain repressor Sloppy paired (Slp) for blocking its
activation by Tin and Smads (in cells receiving both Dpp and
Wg signals) [15].
A number of additional direct tin target genes have been defined
by using candidate approaches based upon genetic and expression
data, particularly with respect to heart development. These
include genes encoding various cardiac transcription factors (tin,
pnr, Hand, svp, mef2, mid) [6], [7], [16]–[19], an ion channel subunit
(Sur) [20], [21], a cytoskeletal component (b3-tubulin) [22], and a
transmembrane receptor (Toll) [23]. All these genes fulfill stringent
criteria for cardiac Tin target genes, i.e., loss (or strong reduction)
of gene expression in tin mutant backgrounds, Tin binding to a
linked cardiac enhancer element, and loss (or strong reduction) of
cardiac enhancer activity upon mutation of the Tin binding motifs.
In most of these cases, only the role of Tin has been defined at the
level of the respective enhancers, but their detailed functional
architectures have not been examined. However, in a few cases
additional direct and obligatory co-regulators were described, in
particular Smads (for the tinD enhancer of tin) [7], Pnr (for a heart
enhancer of Hand) [16], and Doc (for a heart enhancer of Toll)
[23].
Although the candidate approach-based studies were successful
in providing a basic framework of the regulatory circuits during
heart development downstream of tin, for a more complete
picture of the roles of tin it is necessary to recover functionally
important tin target genes at a more global level. A profitable
starting point towards this goal can be the genome-wide
identification of the DNA sequences to which Tin is bound in
vivo. In our present study, we have taken this directed approach
by performing chromatin immunoprecipitations (ChIPs) of Tin-
bound sequences from embryos during early cardiogenesis,
analyzing them globally, and dissecting selected examples of
them functionally. Similar approaches have been initiated by
others in parallel to ours [24], [25], [26], but overall, information
about the functionality of Tin binding to distinct sequences is still
rather limited.
Herein, we present an analysis of the Tin-bound regions and
their linked genes in embryos during mesoderm patterning (3–
5.5 h after egg laying) and during specification of heart,
visceral and somatic muscle progenitors (5–8 h AEL). After
their global characterization, which shows that the linked
genes are associated preferentially with expression and
functions in various mesodermal tissues and, unexpectedly,
also in ectodermal tissues, we present data from our functional
in vivo analysis of ,50 Tin-bound sequences. The overwhelm-
ing majority of these sequences, which were selected largely
among the ,250 regions with highest levels of Tin occupancy
(with the omission of sequences linked to known genes with
ectodermal activities), showed enhancer activities in various
mesodermal tissues, including the entire early mesoderm,
dorsal and cardiac mesoderm, heart, visceral mesoderm,
somatic mesoderm, and Dorsal Median cells. To test whether
Tin binding is functionally relevant, we focused on the subset
of enhancers active in the dorsal and cardiac mesoderm and/
or the heart and demonstrate that all enhancers of this class
require functional tin for being active. For a representative
subset, we tested the in vivo requirements for their Tin binding
motifs, as well as the requirements for the Pnr and Doc binding
motifs that were also present in these enhancers. Further, by
using machine learning approaches we identified a novel motif
as a classifier of cardiac enhancers and show that in three out
of eight tested enhancers this motif is essential for their cardiac
Author Summary
The Drosophila homeodomain protein Tinman was the first
transcription factor found to control the development and
differentiation of the heart in any species. In spite of that,
our knowledge of the number, identities, and mode of
regulation of the downstream target genes of Tinman that
are necessary to exert its cardiogenic functions is still very
incomplete. To address these issues, we have performed a
genome-wide analysis of DNA regions associated with
Tinman-binding in embryos and the genes linked to them.
The combined data from our in-depth in vivo assays of
sequence elements with high Tinman occupancy allow the
following general conclusions: (1) The majority of such
sequences are active as regulatory elements (called
enhancers) in mesodermal tissues that include Tinman-
expressing cells. (2) The enhancers active in the heart
progenitor cells and the heart generally are dependent on
tinman gene activity, whereas those active in non-cardiac
mesoderm are often bound neutrally by Tinman. (3)
Tinman binding motifs in most cases are essential for
cardiac enhancer activity, but in some cases they can be
functionally-redundant with those of other cardiogenic
factors. (4) Tinman-occupied cardiac enhancers are en-
riched for a newly discovered binding motif for an
unknown factor that is functional in vivo.
Functional Motifs of Tin-Bound Cardiac Enhancers
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activity. Altogether, our data indicate that high-level Tin
binding signifies mesodermal enhancer activity, and at least
with respect to highly-occupied cardiac enhancers, in vivo
binding of Tin is almost always essential, although it can be
functionally-redundant with other bound cardiogenic factors.
We discuss the large architectural diversities of the Tin-bound
cardiac enhancers in terms of the arrangement and require-
ment of the binding motifs for the various cardiogenic factors
as well as more general aspects regarding the interpretation of
genome-wide binding data from ChIP analyses.
Results
Identification of genome-wide in vivo targets of Tin
Genome-wide binding sites for Tin in embryos were
determined for two developmental windows, 3–5.5 h and 5–
8 h after egg laying. During the 3–5.5 h window (herein
termed ‘‘Early’’), Tin is expressed initially in the entire
mesoderm (except for the hematopoetic mesoderm) and then
becomes restricted to bilateral dorsal mesodermal areas under
the influence of Dpp signals (Figure 1A). During this stage, Tin
Figure 1. Sequence motifs enriched in Tin binding regions. (A) Schematic drawings of the expression domains of Tinman (red), Doc (green,
hatched), and Pnr (blue, hatched) during the embryonic stages used for chromatin preparations. Grey: mesoderm not expressing any of these factors.
(B) Tin motif recovered using de novo motif discovery in the top 100 peaks and full Early and Late datasets. The Tin motifs discovered in the full Early
and Late dataset are almost identical, while the ones from top 100 peaks show some differences. These Tin motifs closely resemble the motifs derived
from published Tin binding sites with verified in vivo functions (bottom) and previously published Tinman/Nkx2-5 motifs [80]. The Tin motif from the
full datasets is preferentially located in the center (0.5 on X-axis) of ChIP peaks (see Materials and Methods). (C) The AGATAC motif is the most
enriched sixmer in both Early and Late datasets. The core of this motif is the GATA sequence to which a number of TFs, including GATA factor Pnr,
bind to. The AGATAC motif is preferentially located in the centre of ChIP peaks similarly to the Tin motif, but to a slightly lesser extent. (D) The
binding motifs of the T-box factors Mid and Doc2 from SELEX experiments. The Doc2 motif is also located preferentially near the ChIP peak centre,
but to a lesser extent than both Tin and GATA motifs.
doi:10.1371/journal.pgen.1003195.g001
Functional Motifs of Tin-Bound Cardiac Enhancers
PLOS Genetics | www.plosgenetics.org 3 January 2013 | Volume 9 | Issue 1 | e1003195
is known to fulfill key roles in the early specification of heart
progenitors (both cardioblasts and pericardial cells), the trunk
visceral mesoderm, all dorsal somatic muscle founder cells and
specific ventrolateral founders, as well as ventrally-located glia-
like mesodermal cells, termed Dorsal Median (DM) cells.
During the 5–8 h window (termed ‘‘Late’’), the expression of
Tin narrows from the broad dorsal mesodermal domain to the
cardiogenic mesoderm and developing cardioblasts along the
dorsal margin of the mesoderm, as well as to segmental subsets
of trunk visceral mesoderm cells (Figure 1A). At this stage, Tin
continues to act in the determination and diversification of
cardiac cells (reviewed in [1]). The only non-mesodermal
expression of Tin, which is present during both time windows,
occurs in the ectodermal anlagen of the foregut (Figure 1A).
Chromatin immunoprecipitations were performed with our
high quality, immunopurified Tin antibody [4], assayed by
microarray hybridizations (‘‘ChIP-chip’’), and binding peaks were
called using MAT (see Materials and Methods). The 3–5.5 h
dataset included 2536 genome-wide binding peaks. The 5–8 h
dataset yielded 983 binding peaks, of which 846 overlapped with
peaks from the 3–5.5 h dataset. The lower number of peaks in the
‘‘Late’’ dataset above threshold is possibly due to the smaller
proportion of Tin-expressing cells in embryos of this time window,
which results in lower signal-to-noise ratios. In both datasets,
almost half of the Tin-occupied regions were found in introns,
,40% in intergenic regions, and most of the remaining ones in
59UTR-encoding portions of genes (Figure S1A, S1B; Table S1).
16% of the peak summits were found in promoter regions (0 kb to
22 kb) in both datasets. If the binding regions are assigned to the
nearest gene (in either direction) or exons (for intronic peaks), there
are 1530 putative Tin target genes in the 3–5.5 h dataset and 679
in the 5–8 h dataset, of which 613 are shared between both sets
(Table S1).
We compared our binding regions with those obtained in an
independent study of Tin in comparable developmental windows
(Zinzen et al. 2009, [25]). About 34% of the binding regions in our
3–5.5 h dataset overlapped with those in the 4–6 h dataset from
Zinzen et al., and ,60% of our binding regions in the 5–8 h
dataset overlapped with those in their 6–8 h dataset. Conversely,
,92% of their 4–6 h binding regions and ,63% of their 6–8 h
binding regions overlapped with those from our ‘‘Early’’ and
‘‘Late’’ datasets, respectively (Figure S1C, S1D).
We also compared our Tin-bound regions with highly occupied
target (HOT) regions, which are regions displaying a binding
complexity of .8 transcription factors of diverse functions during
blastoderm stages, as determined by the ModENCODE Consor-
tium [27]. Notably, a significant portion of binding regions from
both of our datasets, namely ,38%, overlapped with HOT
regions (Figure S1D).
To obtain a picture of the type of genes that are bound by Tin
preferentially we searched for over-represented Gene Ontology
(GO) terms. As shown in Table S2A, genes encoding transcrip-
tion factors and developmental genes were strongly enriched
among the Tin-bound genes, both in the 3–5.5 h and the 5–8 h
datasets. Of note, the GO terms ‘‘heart development’’, ‘‘meso-
derm development’’ and ‘‘gastrulation’’ that are particularly
relevant to the known functions of tin ranked among the top 25 in
both lists. An analysis for encoded protein domains that are
enriched among the Tin-bound genes showed a preponderance
of various types of DNA-binding domains at the top of both
datasets. In addition, genes likely encoding components of
signalling cascades such as protein kinases, immunoglobulin
domains, EGF-like regions, and leucine-rich domains ranked
near the top of the lists (Table S2B).
We also addressed the question of whether the Tin-bound genes
were expressed preferentially in the tissues in which tin is expressed
and is known to exert its genetic functions. For this purpose, we
used the temporal and spatial annotations from the 3833 genes in
the BDGP embryonic in situ hybridization database that had
yielded ‘‘acceptable quality’’ expression data [28]. Indeed, there
was a significant enrichment of the terms ‘‘trunk mesoderm
primordium’’, ‘‘visceral mesoderm primordium’’, and ‘‘cardiac
mesoderm primordium’’ among the Tin-bound genes both from
the ‘‘Early’’ and ‘‘Late’’ datasets. In addition, terms reflecting the
ectodermal and mesodermal expression domains of Tin in the
head region (ectodermal foregut primordia and head mesoderm)
were highly enriched (Table S3A). Unexpectedly, when all
expression terms were considered, terms related to ectodermal
and neuronal expression domains turned out to be among the
most highly enriched in both of our datasets (Table S3B). This was
not only the case for ectodermal domains of the head, which could
overlap with Tin expression, but also for ectodermal domains of
the trunk including the ventral nerve cord that exclude Tin
expression. As this enrichment also holds true for the subset of
genes containing intronic Tin-binding regions it is unlikely to be a
result of incorrect assignments of flanking genes to the obtained
binding peaks. It is also unlikely that this enrichment is an artefact
due to biases in gene lengths [29], as we do not detect any major
length differences between mesodermally and ectodermally/
neuronally expressed genes, and terms encompassing genes with
much longer average lengths (e.g., ‘‘tracheal primordium’’), were
not enriched (data not shown). Another possible explanation of
these results could be that expression within Tin+ tissues is linked
preferentially to expression in ectodermal and neuronal tissues, but
upon omission of the genes with Tin-overlapping expression
domains there is still a strong bias for ectodermal and neuronal
expression. Likewise, the omission of the genes associated with Tin
binding in HOT regions, which may potentially reflect non-
functional (neutral) binding [50] and could have produced an
artificial bias, did not change the enrichment for ectodermal
tissues (data not shown). It is possible that the observed enrichment
for Tin-bound genes with ectodermal domains reflects a role for
Tin in repressing ectodermal genes but currently, genetic evidence
for such a role is lacking. Alternatively, for unknown reasons non-
functional binding of Tin could occur preferentially in ectoder-
mally-expressed genes. One hypothesis is that Tin can occupy
potential binding sites for the NK-2 type transcription factor
Ventral nervous system defective (Vnd), with which it shares a very
similar binding motif [30] and which may be bound by Tin if the
chromatin is not masked in mesodermal tissues. Interestingly, the
majority of Tin peaks in both early and late conditions are
localized in open chromatin when compared to the genome-wide
DNase I footprint profile generated by the BDTNP for whole
embryos [31], that is, 91% of Tin Early peaks overlap DNA
accessibility sites at stage 9 and 93% of Tin Late peaks overlap
DNA accessibility sites at stage 11.
Tin and GATA factor binding motifs are enriched in Tin-
bound regions
To determine whether the Tin-bound regions contained any
prevalent sequence motifs we performed a de novo motif search
using Regulatory Sequence Analysis Tools (RSAT) [32] on repeat-
masked DNA [33] from 3–5.5 h and 5–8 h Tin peak regions.
With both the top 100 peaks and the total datasets from each
developmental window, we retrieved the known Tin binding
motif, which closely resembled the motif obtained with function-
ally-tested Tin target sites that were published at the beginning of
our study (Figure 1B; Table S5). In addition, the consistently most
Functional Motifs of Tin-Bound Cardiac Enhancers
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enriched six-mer core motif AGATAC closely resembles the motif
bound by various GATA factors, including that of the vertebrate
cardiogenic factor GATA-6 (Figure 1C). In Drosophila, the GATA-
4/-5/-6-related factor Pannier (Pnr) is known to play a key role in
early heart development [34]–[][36]. We found that the de novo
motifs presumed to bind Tin and GATA (Pnr) are located
preferentially in the center of enriched binding regions (Figure 1B
and 1C). This preference was less pronounced for the motifs of the
cardiac T-box factor Dorsocross 2 (Doc2) (determined by SELEX;
Figure 1D; Table S5). Closely related Tin and GATA motifs were
also derived de novo from Tin and Pnr-bound sequences,
respectively, by Junion et al. [26], whereas their Doc de novo motif
deviates significantly from the SELEX-derived motifs for Doc
(Figure 1D) and the related Tbx6 [37].
Most tested Tin-bound regions act as enhancers in
various mesodermal tissues
In a first step towards testing the observed Tin-bound regions
functionally we ranked the binding peaks according to their size (as
defined by the area underneath the contour), with the assumption
that on average the regions bound more strongly (e.g., because of
the presence of multiple binding sites, high affinity sites, or of
binding sites for other Tin-binding factors that increase occupancy
by Tin) would be more likely candidates for functional Tin targets
[38]. As shown in the ranking lists for the 3–5.5 h and 5–8 h
datasets of the top ,450 peaks (Table S4A, S4B), the majority of
known Tin downstream genes and proven Tin targets genes,
defined previously via genetic and/or molecular data, were
present among the genes associated with the top-ranking binding
peaks. These included, in the ‘‘Early’’ (E) and ‘‘Late’’ (L) lists,
respectively: tup (rank #E9, L34), bap (#E10, E198, L352), mid
(#E19, L298, L350, L402, L411), H15 (#E22, L5), mir-1 (#E43,
E119, E155, L100), , eya (#E91, E128, L57, L165), Doc genes
(#E105, E122, E282, L33), Poxm (#E138, L276), zfh1 (#E141,
L173, L227, L348), mef2 (#E170, E181, L341), jeb (#E177), odd
(#E81, L181; #E254, L164), Six4 (#E255), pnr (#E261, L162),
slou (#E273, E425, L140), lbe (#E308, L170), Him (#E318, L47),
Tl (#E359), disco (#E420, L10, L217, L286), btn (#E455), apt
(#L133, L336), svp (#L216, L330), htl (#L383), lbl (#L443), and
tin (#L424). Apart from these, the top-ranking genes included
many that are expressed in mesodermal tissues with patterns that
overlap spatially and temporally with Tin (Table S4A, S4B).
For functional tests of enhancer activity in vivo we selected 51
binding regions (Table S4A, S4B). The following criteria were
employed for the selection: 1) Higher priority was given to regions
ranking higher on the size-ranked lists. 2) Lower priority was given
to fragments that did not include at least one high-scoring Tin
binding motif (Materials and Methods, Table S5). 3) Excluded
were fragments associated with genes with published expression
patterns that do not include mesodermal tissues. Thus, potential
Tin targets in the Tin+ ectodermal foregut primordia were also
omitted. The initial fragments had an average length of 1.4 kb and
the endpoints were chosen such that the fragments were centered
around the peak maxima and included any Tin motifs underneath
the peaks.
39 of the 51 fragments tested (76%) were active in mesodermal
domains overlapping with Tin domains. Among these, 16 (41%)
were active in the cardiogenic mesoderm and/or in the
developing heart, which were of particular interest to our study,
and one (associated with nau) was active in the early dorsal
somatic mesoderm (Figure 2; see Figure S2 for zfh1E141, which
exhibits very weak activity in the dorsal vessel after stage 14;
Tables S3A, S3B and S4). Several of these putative cardiac target
enhancers of Tin were active additionally in cells of the somatic
or visceral mesoderm (Figure 2; Tables S3A, S3B and S4). The
onset of reporter expression within dorsal mesodermal and
cardiogenic regions with these fragments included the time
windows assayed in the ChIP experiments and the corresponding
enhancers showed peaks in both the 3–5.5 h and the 5–8 h
windows. Notably, several enhancers only began showing cardiac
activity during the 5–8 h window, even though Tin binding was
already detected during the 3–5.5 h window (Figure 2; lin-28L64,
midE19, unc-5L25, CG3638L6) (note that the enhancers are
named after the presumed associated gene and their highest rank
in the Early and Late lists, respectively; Table S4). Conversely,
other enhancers were still occupied by Tin in the 5–8 h window,
but their activity in the dorsal mesoderm and developing heart
had ceased during this period (Figure 2, discoL10, nauL35,
CG9973E15, and data not shown). However, most of the cardiac
enhancers remained active in developing cardioblasts and/or
pericardial cells until stages 14–16 (Figure 2, EgfrE1, fzL4,
HimL47, hthE54, lin-28L64, maL9, midE19, nocL7, tshL8,
tupE9, unc-5L25).
14 of the 39 positive fragments (36%) were active in the
somatic mesoderm but not in the cardiogenic mesoderm (Figure
S2). Half of these showed activity in the whole somatic
mesoderm. Among these were fragments associated with zfh1
(with additional weak expression in cardiac mesoderm), CG5522,
CG32792 and, surprisingly, H15 and hh, two genes that are not
known to be expressed in the somatic mesoderm. The other half
showed activity in more restricted patterns in the somatic
mesoderm, such as in large lateral cell clusters (lbeL170),
segmental stripes (slpE35), and stripes restricted to ventral areas
(PoxmE138, Six4E255).
6 of the positive fragments (15%) tested positive in the
primordia of the trunk visceral mesoderm and one (oddE81) in fat
body primordia (Figure S3). These included fragments near the
genes Alk, Fas3, and H2.0, which are known to be expressed in
the trunk visceral mesoderm. The enhancers of both Alk and Fas3
start being active in the entire segmental visceral mesoderm
primordia during the 3–5.5 h window (Figure S3A, S3B),
whereas those of Gukh, Nrt and H2.0 become active only during
the 5–8 h window with their activity being restricted to the
ventral rows of circular gut muscle founder cells (Figure S3C–
S3E; wgnE1197-LacZ appears in portions of visceral mesoderm
only at stage 14, Figure S3F). The remaining two positive
fragments showed activity in the Dorsal Median (DM) cells,
which form in the mesoderm along the ventral midline in each
segment and later are attached dorsally to the CNS (Figure S4).
The DM cells are known to depend on tin function, which must
be needed during early stages when Tin expression is still present
in ventral areas of the mesoderm (i.e., during our 3–5.5 h test
window) [39]. In contrast to the above enhancer activities that
overlap with Tin expression domains in the mesoderm, 12
additional enhancer fragments were active in a variety of non-
mesodermal tissues and cell types that are mostly ectodermally-
derived (Figure S5). A comparison with the genomic ChIP data
published by Junion et al. [26] subsequent to our in vivo analysis
shows that 50 of our 51 enhancer regions tested in vivo and all ten
positive control enhancers used are also positive for Tin
occupancy in their screens (the exception being the low ranking
wgnE1197), and are often positive for various combinations of
Doc, Pnr, pMad, and dTCF (Table S5). Perhaps unexpectedly,
the 61 mesodermal and non-mesodermal enhancers can not be
differentiated via their occupancy patterns by these factors, e.g.,
within each of the mesodermal (any tissue), cardiac, and non-
mesodermal subset ,1/3 of the enhancers are occupied by
Tin+Doc+Pnr, ,1/3 by Tin+Doc, and ,1/3 by Tin only (Table
Functional Motifs of Tin-Bound Cardiac Enhancers
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S5). In addition, when we overlap our list of 61 enhancers with
the ChIP data and predicted clusters of Junion et al., we find
neither their individual ChIP signals nor any of their predicted
ChIP cluster types to be significantly associated with cardiac
enhancers (Fisher’s exact test, P-value.0.10; a subtle association
could have been missed because of the size of the dataset).
To get an overview of the involvement of tin in generating
the observed patterns of mesodermal enhancer activity we
tested a selection of the reporters from each class in tin mutant
backgrounds. As shown in Figure S6A, S6A9, S6C, S6C9, S6H,
S6H9, the enhancer activities of AlkE301, Fas3L254, and
NrtL30 in the visceral mesoderm are severely reduced or
absent in tin mutant embryos. Likewise, the activity of the btn
enhancer in DM cells (Figure S6B, S6B9) and of the enhancers
of hth (Figure S6D, S6D9, arrows) and noc (Figure S6G, S6G9)
in cardiogenic regions is strictly tin-dependent. In contrast, the
results for somatic mesodermal enhancers were more varied.
Whereas the dorsal somatic mesoderm activities of the nau and
noc enhancers were strictly dependent on tin (Figure S6F, S6F9,
S6G, S6G9), the ventral somatic mesoderm activity of the Six4
enhancer was reduced only slightly in tin mutants (Figure S6I,
S6I9) and the somatic mesoderm activity of the hth and zfh1
Figure 2. Tin binding and reporter activity of enhancers active in dorsal mesodermal cells, cardiac progenitors and heart
progenitors. (A–P) show the Tin binding peaks (blue: 3–5.5 hrs: pink: 5–8 hrs AEL), the location of the tested enhancers (yellow bars) and the gene
models (red: genes closest to tested fragment). Y axes are at identical scales whereas x axis scales are variable (see scale bars). A9 to P9 show enhancer
activities at earliest stage of appearance (arrow or arrow heads: dorsal/cardiac mesoderm) and A0 to P0 at latest stage of detection in cardiac tissues
(arrows or arrow heads). Shown are GFP or lacZ in situ hybridizations except in A0, I9, I0 and P0, which show anti-GFP antibody stainings (in A0, I0 and P0
perduring GFP from earlier expression). Genes are ordered alphabetically, with CGs last. (A9) Stage 12. Expression of discoL10-GFP in heart progenitors,
segmental subsets of visceral muscle precursors and (A0), stage 14, perdurance of GFP in developing visceral muscles and heart. (B9, B0) Expression of
EgfrE1-lacZ in cardioblast progenitors and subsets of somatic mesodermal cells (stage 12), and in cardioblasts (stage 14). (C9, C0) Expression of fzL4-
GFP in cardioblast progenitors (stage 12) and in cardioblasts and amnioserosa (stage 14). (D9, D0) Expression of HimL47-GFP in cardiogenic mesoderm
and somatic mesodermal cells (stage 12), and in cardioblasts and developing somatic muscles (stage 14). (E9, E0) Expression of hthE54-GFP in heart
progenitors of Md, T1–T3 segments (arrow heads) and in somatic mesoderm (with A–P graded sizes of clusters) (stage 12) and in anterior developing
heart cells (arrow head) and somatic muscles (stage 14). (F9, F0) Expression of lin-28L64-GFP in cardioblasts (stage 12, stage14). (G9, G0) Expression of
maL9-GFP in cardiac and somatic mesoderm (stage 12) and in heart precursors (stage 14). (H9, H0) Expression ofmidE19-GFP in Tin+ cardioblasts (stage
12, stage 15). (I9, I0) Expression (I9, stage 12) and perdurance (I0 stage 14) of nauL35-GFP largely in dorsal somatic mesoderm (asterisks). (J9, J0)
Expression of nocL7-GFP in pericardial cell progenitors (stage 12) and pericardial cells (stage 16). (K9, K0) Expression of RhoLE102-GFP in segmented
dorsal mesoderm (stage 11) and cardioblast progenitors (stage 12). (L9, L0) Expression of tshL8-lacZ in cardiogenic mesoderm and thoracic ectoderm
(stage 11) and in Tin+ pericardial cells (stage 15). (M9, M0) Expression of tupE9-GFP in cardiogenic mesoderm (stage 11) and cardioblasts (stage 14). (N9,
N0) Expression of unc-5L25-GFP in cardioblast and pericardial cell progenitors (stage 12) and in cardioblasts and Tin+ pericardial cell (stage 16). (O9, O0)
Expression of CG3638L6-GFP in cardioblast progenitors (stage 12) and cardioblasts (stage 15). (P9, P0) Expression of CG9973E15-GFP in cardiac
mesoderm (stage 11) and perdurance of GFP in developing heart (stage 14).
doi:10.1371/journal.pgen.1003195.g002
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enhancers was completely tin-independent (Figure S6D, S6D9,
S6J, S6J9). In summary, the selected fragments showing in vivo
Tin binding were highly enriched for sequences containing
enhancer activities in tissues with known genetic requirements
for tin. Particularly the activities of the heart and visceral
mesoderm enhancers appear to depend on tin, whereas the tin-
dependency of somatic mesoderm enhancers seems less
predictable.
All tested enhancers active in early cardiogenic regions
and in the mature dorsal vessel are tin dependent
For the remainder of the study we concentrated on the
characterization of the identified enhancers that were active in
the cardiogenic mesoderm and developing heart. We verified that
all of the enhancers with activities assigned to the cardiogenic
mesoderm and heart progenitors during the developmental
windows assayed by ChIP were indeed active in Tin-positive cells
(Figure 3A–3J). The exact patterns varied, with some enhancers
being active in all cells of the segmental cardiogenic anlagen (e.g.,
HimL47, tupE9, Figure 3C, 3H) and others becoming active
shortly afterwards in newly-specified, segmentally arranged heart
progenitors (e.g., fzL4, midE19, tshL8, unc-5L25, CG3638L6;
Figure 3A, 3E, 3G, 3I, 3J) or throughout the cardiogenic
mesoderm (EgfrE1, lin-28L64, Figure 3A, 3D). When assayed in
tin null mutant backgrounds, the activities of all these enhancers in
cardiogenic regions and heart progenitors were completely lost
(Figure 3A9–3J9). By contrast, if enhancers were also active in other
mesodermal areas, such as the somatic mesoderm (EgfrE1,
HimL47, RhoLE102, unc-5L25; Figure 3A9, 3C9, 3F9, 3I9) or in
amnioserosa and ectodermal tissues (lin-28L64, tshL8; Figure 3D9,
3G9), these non-cardiac activities did not require tin.
Whereas the activities of some of the assayed cardiac enhancers
were transient and ceased by germ band retraction, the activities of
several others persisted in the dorsal vessel until late stages of
embryogenesis. The midE19 and tupE9 enhancers were active
only in cardioblasts (especially in Tin+ cardioblasts) and the unc-
5L25 and CG3638L6 enhancers in both cardioblasts and
pericardial cells (Figure 4A–4D). To test whether these enhancer
activities within cells of the dorsal vessel are also tin dependent we
used a ‘‘conditional’’ tin mutant background, in which Tin is still
expressed during early mesoderm patterning and heart progenitor
specification but not in cardioblasts and pericardial cells after they
are formed [9]. As shown in Figure 4A9–4D9, the activities of all
Figure 3. Dependency of early cardiac enhancer activities on
tin. Shown are stage 11–12 embryos stained for enhancer activities
(anti-bGal or anti-GFP) and Tin (green). (A–K) Enhancer activities in wild
type backgrounds (left corner quadrants: anti-Tin omitted for better
visualization of reporter patterns; arrow heads: early cardiac expression).
(A9–K9) Enhancer activities in homozygous tin346 mutant backgrounds.
(A, A9) EgfrE1-LacZ expression in cardiac mesoderm but not in somatic
mesoderm (asterisks) requires tin. (B, B9) fzL4-GFP expression in
cardioblast progenitors requires tin. (C, C9) High-level HimL47-GFP
expression in cardiogenic mesoderm requires tin but somatic meso-
dermal expression does not. (D, D9) lin-28L64-GFP expression in cardiac
mesoderm requires tin. Amnioserosa expression is unaffected in tin
mutants. (E, E9) midE19-GFP expression in cardioblast progenitors
requires tin. (F, F9) RhoLE102-GFP expression in cardiogenic mesoderm,
but not in somatic mesoderm, requires tin. (G, G9) tshL8-LacZ expression
in cardiogenic mesoderm, but not in somatic mesoderm, requires tin.
(H, H9) tupE9-GFP expression in cardiogenic mesoderm requires tin. (I, I9)
unc-5L25-GFP expression in cardiac mesoderm but not in somatic
mesoderm requires tin. (J, J9) CG3638L6-GFP expression in cardioblast
progenitors requires tin. (K, K9) CG9973E15-GFP expression in cardioblast
progenitors requires tin.
doi:10.1371/journal.pgen.1003195.g003
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four of these enhancers in cardioblasts (marked by Doc) and
pericardial cells are nearly absent if Tin is not present in these
cells. In summary, we found that all identified enhancers that drive
expression in the cardiogenic mesoderm, heart progenitors, and
cells of the dorsal vessel are strongly dependent on tin. Hence,
these enhancers were strong candidates for direct functional
targets of tin.
Differential in vivo requirements for the binding motifs of
the cardiogenic factors Tin, Pnr, and Doc
Next, we tested the in vivo relevance of the Tin binding sites in
selected cardiac enhancers under investigation. Because the
binding motif for the cardiogenic GATA factor Pnr had been
prevalent among the genome-wide Tin-bound regions (Figure 1),
and because the T-box factors Doc1-3 are known to have key
functions during early cardiogenesis and cardioblast diversification
as well [8], we also included the binding motifs of Pnr and Doc in
this analysis. We note that the Doc binding motifs are closely
related to the binding motifs for the Tbx20 cardiac T-box factors
Midline (Mid) and H15 (Figure 1D). Thus, from stage 12 when
these Tbx20 factors are expressed in cardioblast progenitors, the
T-box binding motifs may be occupied either by Doc or Tbx20
factors.
Figure 5A1–5F1 shows the distribution of the Tin, Pnr, and Doc
binding motifs within the cardiac enhancers from Egfr, lin-28, mid,
RhoL, tup, and unc-5. The Tin matrix from proven target genes
(Figure 1B), the SELEX-based matrix from the Pnr-related
vertebrate cardiogenic factor GATA-6 with GATA core sequence
[40], and our SELEX-based Doc2 motif (Figure 1D) were used to
locate and score binding motifs. Subsequent to our functional
Figure 4. Dependency of late cardiac enhancer activities within the dorsal vessel on tin. Shown are reporter activities (anti-GFP, green),
Tin+ cardioblasts and pericardial cells (anti-Tin, red) and Doc+ cardioblasts (anti-Doc, blue) in stage 15–16 control embryos (A–D) and in embryos
specifically lacking Tin activity in cardiac cells (tinABD, tin346; A9–D9). (A) midE19-GFP is expressed specifically in the Tin+ cardioblasts. (A9) Absence of
cardiac Tin expression causes a severe reduction of midE19-GFP activity. (B) tupE9-GFP is highly expressed in Tin+ cardioblasts (graded posteriorly-to-
anteriorly) and, at much lower levels perduring from stage 12 expression, is present in Doc+ cardioblasts, pericardial cells, and dorsal somatic muscles.
(B9) Upon loss of cardiac Tin expression almost all cardioblasts contain only low levels of perduring GFP. (C) unc-5L25-GFP expression in pericardial
cells and (largely posteriorly) in cardioblasts. (C9) Absence of cardiac Tin expression causes near loss of cardioblast unc-5L25-GFP expression and a
reduction of expression in pericardial cells. (D) CG3638L6-GFP is expressed in Tin+ cardioblasts (with variable intensities) and in Tin+ pericardial cells.
(D9) Absence of cardiac Tin expression causes nearly complete loss of CG3638L6-GFP expression.
doi:10.1371/journal.pgen.1003195.g004
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analysis, Junion et al. [26] found regions overlapping with our
enhancers from Egfr, lin-28, RhoL, and unc-5 to be occupied by all
three cardiogenic factors, whereas the mid and tup enhancers
appeared to be solely occupied by Tin (Table S5). For all six
chosen enhancers, shortened versions (,600–800 bp) were used
for functional analysis of binding motifs, named EgfrE1s, lin-
28L64s, midE19s, RhoLE102s, tupE9s and unc-5L25s (Tables S4,
S5). All enhancers examined included binding motifs for all three
cardiogenic factors except for the EgfrE1s enhancer, which lacked
Doc motifs. The numbers and spatial arrangements of these motifs
within the different enhancers were quite variable (Figure 5A1–
5F1).
In the EgfrE1s enhancer, the Tin motifs were essential for
enhancer activity in the cardiogenic mesoderm, but not in the
somatic mesoderm (Figure 5A3, cf. Figure 5A2). Mutation of the
GATA (Pnr) motifs caused a weakening of the cardiac versus
somatic mesodermal enhancer activity at early stage 12
(Figure 5A4), which became even more pronounced during stage
13 (Figure 5A6, cf. Figure 5A5).
In the lin-28L64s enhancer, the Tin motifs were essential for
cardioblast activity, and the GATA sites were essential for both
cardioblast and amnioserosa activity (Figure 5B3, B4, cf.
Figure 5B2; note that Pnr expression includes both the cardiogenic
mesoderm and the amnioserosa, as well as the dorsal ectoderm).
Figure 5. In vivo assays of the functions of predicted binding sites of Tin, Doc, and Pnr in identified cardiac enhancers. (A1–F1)
Positions, orientations, and scores of predicted binding sites within cardiac enhancers (identical Y-scales). In vivo results for functionality of binding
sites are summarized to the right (large 3: essential; small (3): required for full activity or redundantly with motifs for other factors;6not required).
(A2, A3) EgfrE1s-GFP activity in cardiac mesoderm (A2, stage 12) is lost upon mutation of Tin binding motifs shown in (A1). (A4–A6) Mutation of GATA
motifs shown in (A1) leads to a mild reduction of EgfrE1s-GFP activity at stage 12 (A4) and a more significant reduction at stage 14 (A6). (B2, B3) lin-
28L64s-GFP activity in cardioblasts (B2, stage 14) is lost upon mutation of Tin binding motifs. (B4) Mutation of GATA motifs leads to loss of lin-28L64s-
GFP activity in both cardioblasts and amnioserosa cells. (B5) Mutation of Doc binding motifs affects neither cardioblast nor amnioserosa activity of lin-
28L64s-GFP. (C1, C2) midE19s-GFP activity in cardioblasts (C2, stage 15) is lost upon mutation of Tin binding motifs (C3). (C4) Mutation of GATA motifs
does not affect midE19s-GFP activity. (C5) Mutation of Doc binding motifs reduces cardioblast midE19s-GFP activity. (D2–D4) Mutation of the binding
motifs for Tin (D3) or Pnr (D4) does not affect RhoLE102s-GFP activity in the cardiogenic and dorsal somatic mesoderm. (D5) Mutation of Doc binding
motifs causes loss of RhoLE102s-GFP activity in cardiogenic and dorsal somatic mesoderm. (E2, E3) Mutation of Tin binding motifs causes loss of
tupE9s-GFP activity in dorsal and cardiogenic mesoderm (ms). Ectopic tupE9s-GFP occurs in dorsal ectoderm (ec). (E4, E5) Mutation of GATA motifs
(E4) or Doc binding motifs (E5) does not affect tupE9s-GFP activity. (F2–F5) Mutation of either the Tin binding motifs (F3), the GATA motifs (F4) or the
Doc binding motifs (F5) does not affect unc-5L25s-GFP activity in cardioblasts and pericardial cells at stage 15. Three sequences, CCAAGGG, TCAATTG,
TCGAGTG, poorly matching the Tin binding motif (Figure 1, Table S5), are still present but it is unknown whether they can bind Tin. (F6) Staining of
stage 15 unc-5L25s-GFP control embryo for GFP and Tin identifies GFP-positive cells as cardioblasts (arrow heads) and Tin+ pericardial cells (arrows).
(F7) Simultaneous mutation of Tin binding motifs and GATA motifs does not affect cardiac unc-5L25s-GFP activity. (F8) Simultaneous mutation of Tin
and Doc binding motifs severely reduces unc-5L25s-GFP activity in cardioblasts but not in pericardial cells. (F9) Simultaneous mutation of binding
motifs for Tin, Pnr, and Doc abrogates unc-5L25s-GFP activity (anti-GFP, green) in cardioblasts but not in pericardial cells (anti-Eve, red).
doi:10.1371/journal.pgen.1003195.g005
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By contrast, the Doc motifs were not essential for lin-28L64s
enhancer activity (Figure 5B5).
In the midE19s enhancer, the Tin motifs were essential for
its activity in cardioblasts (Figure 5C3, cf. Figure 5C2, see also
[19]). Mutation of the GATA motifs did not have any effects,
but mutation of the Doc motifs led to a strong reduction of
enhancer activity in the Tin+ cardioblasts (Figure 5C5). It is
conceivable that this effect is caused not only by the failure to
bind Doc during heart progenitor specification but also by the
inability to bind Mid, which may prevent maintenance of
activity by autoregulation (in combination with Tin) in
developing cardioblasts. A second effect of the Doc-site
mutations was a moderate upregulation in the Tin2/Doc+
subset of cardioblasts, in which this particular enhancer is
normally not active although mid is expressed there. Thus, the
combined effects of the Doc site mutations lead to weak
uniform enhancer activity in all cardioblasts. These observa-
tions point to an unexpected complexity of mid regulation
through both positive and negative effects of cardiogenic
regulators and to the existence of yet unidentified regulatory
elements for expression in the Tin2/Doc+ cardioblasts.
The RhoLE102s enhancer was active in the cardiogenic
mesoderm even after mutation of any decent Tin motifs, which
was unexpected (Figure 5D3, cf. Figure 5D2). Although one
low-scoring sequence motif, CCAAGGG is still present in the
mutated version, this particular sequence deviates significantly
from the motifs shown in Figure 1A and is not known to bind
Tin in vitro. Mutations of the GATA motifs also did not have
any effects (Figure 5D4). However, in the absence of the Doc
motifs the RhoLE102s enhancer was inactive (Figure 5D5).
In the tupE9s enhancer, only the Tin motifs were required
for its activity in the cardiogenic mesoderm, whereas the
GATA and Doc motifs were not essential (Figure 5E3, cf.
Figure 5E2, 5E4, 5E5). These results are compatible with the
absence of in vivo binding by Pnr and Doc [26]. Upon mutation
of the Tin binding sites, enhancer activity in the dorsal
mesoderm was completely lost and instead, ectopic segmental
activity in the dorsal ectoderm appeared. Of note, a similar
switch in germ layer activities has also been observed upon
mutation of the dorsal mesodermal enhancers of tin and bap.
For these two examples, it was found that Tin acts synergis-
tically with Smads bound to nearby sites during the activation
of the enhancers in dorsal areas of the mesoderm. By contrast,
in the dorsal ectoderm an unknown repressor with a
recognition site that overlaps with the Tin motif was proposed
to bind and prevent ectodermal enhancer activation by Dpp
and activated Smads [7]. The tup enhancer appears to be a
third example for this regulatory mechanism to achieve germ
layer specificity of the Dpp response.
Surprisingly, for the unc-5L25s enhancer neither mutation of
the Tin motifs nor of the GATA or Doc motifs had any
measurable effect on its activity in cardioblasts and pericardial
cells (Figure 5F3, 5F4, 5F5, cf. Figure 5F2). We can not exclude
that Tin can still bind and provide full activity through three
low-scoring candidate Tinman motifs that were not mutated (see
Figure 5, legend). Alternatively, or in addition, there is the
Figure 6. Cardiac enhancers classifier. (A) The motifs with bootstrap confidence over 65%. The confidence levels are shown as bars and are
colour-coded with darker color for larger confidence. The motif with the greatest confidence was the de novo CEE motif followed by another de novo
motif somatic1. The GATA motif and the fkh motif from JASPAR had smaller confidence. As expected, Tin motifs were not retrieved as all fragments
had been selected based upon high Tin occupancy, which in most cases involves Tin motifs, whereas the classifier was trained to distinguish between
the two groups of enhancers. (In addition, the exact borders of both the cardiac and non-cardiac enhancers had been adjusted for their inclusion of
one or more Tin motifs, if present within the binding peak region). (B) The regression coefficients in the final classifier that contains only the 4 motifs
with .65% confidence. During classifier training the cardiac enhancers were given a target value of 1 and the rest of enhancers 21. Enhancers are
scored by multiplying the regression coefficients with the standardized motif hit density (standardized to zero mean and unit variance over the whole
dataset) in the sequence. Thus, a positive regression coefficient indicates that the above-average motif presence predicts cardiac enhancers, and
negative that it predicts non-cardiac enhancers. The motif with the largest positive regression coefficient is the CEE motif followed by GATA. GATA
(Pnr) is a known co-factor of Tin, which we further verified in our mutation analysis, while CEE was the novel predicted motif (see main text). Presence
of two motifs: somatic1 and fkh predicted the non-cardiac enhancers. Somatic1 is another de novo motif we discovered (see Materials and Methods)
but which we did not test functionally, while fkh indicates that a protein from the forkhead family likely binds to those Tin-bound enhancers that are
not active in the cardiac cells but in other parts of the mesoderm. Note that the AUC score shown is an overly optimistic estimate of real
generalization error due to selection bias [58].
doi:10.1371/journal.pgen.1003195.g006
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possibility of functional redundancy among these three factors
and their binding sites within this enhancer, which we tested
with derivatives containing combinatorial mutations in the
different motifs. When the Tin and GATA motifs were mutated
in combination, there was still no change in the cardiac activity
of the enhancer (Figure 5F7). By contrast, simultaneous mutation
of both the Tin and Doc motifs caused near absence of enhancer
activity in cardioblasts, whereas its activity in pericardial cells
was unaffected (Figure 5F8). Additional mutation of the GATA
motifs had only minor additive effects on the reduction of
enhancer activity, which showed only residual expression in Eve+
pericardial cells (Figure 5F9, cf. Figure 5F6, 5F8). Hence, we
propose that in the case of the unc-5 enhancer, binding of either
Tin or Doc (and perhaps Mid) to the Tin or T-box motifs,
respectively, is functionally relevant but either factor alone is
largely sufficient for activating the enhancer.
De novo motif discovery of a sequence motif enriched in
cardiac enhancers
We used machine learning methods to test whether we can
predict cardiac enhancers based on their motif content, as had
previously been shown for human heart enhancers [74]. For this
analysis, we added ten well-characterized Tin-dependent en-
hancers that are active in cardiogenic tissues, visceral mesoderm,
or somatic mesodermal cells to the collection described herein,
which yielded 24 cardiac enhancers and a total of 61 enhancers
to be examined (Table S5). The enhancers were classified
according to their tissue-specific activity patterns as denoted in
the above table. First we undertook extensive de novo motif
discovery using RSAT [32] on each experimentally verified
enhancer class separately and between pairs of enhancer classes.
This yielded 33 de novo motifs, which we put together with
previously described motifs in Drosophila (see Materials and
Methods). To prioritize motifs predictive in cardiac enhancers
we constructed a LASSO classifier to predict the 24 cardiac
enhancers from the set of 61 experimentally verified enhancers
(Narlikar et al., 2010). Since our set of enhancers is small and we
wanted to assign confidence values to predictive motifs, we used
a bootstrap modification of LASSO called bolasso [41]. We
found one de novo motif to be especially predictive of the cardiac
class, ATT[TG]CC, which we termed ‘‘Cardiac Enhancer-
Enriched (CEE) Motif’’. This motif has a bootstrap confidence of
Figure 7. In vivo assays of the function of the CEE motifs in selected cardiac enhancers. (A1, B1, C1) Schematic drawings of the predicted
Tin, Pnr, and Doc binding sites within cardiac enhancers as in Figure 5 and the positions of the CEE motifs relative to these (green bars). (A2–A5)
Mutation of the CEE motifs causes a strong reduction of EgfrE1s-GFP activity in cardioblast progenitors at stage 12 (A2, A3) and in cardioblasts at
stage 14 (A4, A5). (B2–B5) Mutation of the CEE motifs leads to the absence of lin-28L64s-GFP activity in heart precursors (and amnioserosa cells) at
stage 14 (B2, B3) and a reduced activity in cardioblasts and pericardial cells at stage 16 (B4, B5). (C2, C3) Mutation of the CEE motifs causes almost
complete loss of midE19s-GFP activity in Tin+ cardioblasts (stage 16).
doi:10.1371/journal.pgen.1003195.g007
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96% and its presence is the strongest predictor of cardiac
enhancers followed by the GATA motif (Figure 6). In several
sequences with cardiac activity, the CEE motif is particularly
frequent, namely in midE19 (6.9 motif hits per kb), mef2 I-E (5.3
per kb), mef2 II-B[S] (4.3 per kb) [42], lin-28L64 (4.2 per kb),
hthE54 (4.1 per kb), zfh1E141 (4.1 per kb) and sli (3.8 per kb).
The enhancers with cardiac activity have an average density of
2.86 CEE motif hits per kb. In contrast, the experimentally
verified enhancers with no cardiac activity have the average
density of 1.52 per kb of sequence, which is almost identical to
that in 2 kb Drosophila gene upstream regions (1.53 CEE motif
hits per kb).
Because of the relatively small size of the enhancer dataset we
needed to use all of the data for de novo motif finding and model
selection, which can lead to an over-estimation of the AUC. For
this reason, it was important to test the predictions of the classifier
(namely the CEE motif) for their in vivo relevance in transgenic
animals carrying reporter constructs in which the CEE motifs were
mutated. We included all enhancer fragments that were also tested
for functionality of the Tin, Doc, and GATA motifs and in
addition, the published cardiac mef2 enhancers I-E and II-B[S]. As
shown in Figure 7, in three of these fragments the CEE site
mutations caused severe reductions of their cardiac enhancer
activity. In EgfrE1s, enhancer activity in heart progenitors at stage
12 (Figure 7A3, cf. Figure 7A2) and particularly in cardioblasts
following stage 13 (Figure 6A4, cf. Figure 6A3) was strongly
reduced, whereas the activity in the somatic mesoderm was
unaffected. In lin-28L64s, CEE site mutation caused loss of
enhancer activity in cardiac cells in embryos until stage 14
(Figure 7B3, cf. Figure 7B2). Activity in the amnioserosa was also
lost, whereas head expression was unaffected. In the maturing
dorsal vessel, the CEE site-mutated lin-28L64s enhancer regained
some activity, particularly in pericardial cells, but its activity in
cardioblasts remained much lower than that of the unmutated
control (Figure 7B5, cf. Figure 7B4). For the midE19s enhancer,
CEE site mutations caused a complete loss of activity in the vast
majority of Tin+ cardioblasts. In rare remaining positive cardio-
blasts, nearly full activity was seen (Figure 7C3, cf. Figure 7C2).
These results were very similar to the results obtained with Tin site
mutations for these three enhancers, and for EgfrE1s and lin-
28L64s also with the GATA site mutations, even though the CEE
motifs do not overlap with any of the Tin and GATA motifs
(Figure 7A1, 7B1, 7C1). Altogether, we hypothesize that the CEE
motifs bind a yet unknown co-factor of these cardiogenic factors.
At least in the cases of EgfrE1s, lin-28L64s, and midE19s, the
combination of this co-factor and one or several of the cardiogenic
factors is needed for activating the respective enhancer in cardiac
cells. Although the verification rate of three functional CEE motifs
out of eight may seem modest, it is in the same range as found for
the Doc motifs (2/5) and GATA motifs (2/6). It remains to be
shown whether this factor is not functional in the other five
enhancers tested, in which CEE site mutations did not cause any
noticeable differences in cardiac activity. Alternatively, it is
conceivable that in the negative cases additional, degenerate
versions of this sequence motif were present and functional, or that
there are additional binding sites for different co-factors that
function redundantly with the putative ATT[TG]CC binding
factor.
Discussion
Although the developmental functions of tin during mesodermal
tissue and particularly heart formation have been defined in quite
some detail by genetic approaches, it is far from being clear how
many target genes of tin are involved in executing these functions.
Candidate approaches based on genetic observations have led to the
identification of a relatively small number of essential Tin
downstream targets, most of which correspond to members of the
transcriptional network controlling the development of the heart,
visceral muscles, and specific body wall muscles. The chromatin
immunoprecipitation approach taken in our present study, as well as
in studies performed in parallel by others [24], [25], provides a
picture of the upper limit of potential Tin target genes that could be
relevant biologically, although this number still depends on the
specific cut-off used. With this latter approach, the challenge is to
determine the particular fraction of genes associated with Tin binding
in vivo that indeed require tin and are utilized for implementing the
various tin dependent programs of mesodermal tissue development.
In our present study we have begun to address this issue with a
combination of genetic tests and enhancer dissections.
Global aspects of Tin occupancy and the question of
functionality of binding
A comparison between the Tin-bound regions from our study
and that of Zinzen et al. [25], which were done using very similar
developmental time windows, shows strong overlaps. In addition,
almost all enhancers known to be targeted directly by Tin during
the tested time windows and the large majority of known tin
downstream genes were found to be associated with in vivo Tin
binding. The overall similarity of binding data obtained in
different labs corroborates that a majority of reported peaks
reflects authentic in vivo occupancy although there can be
differences in sensitivities. For example, the number of Tin-peaks
in our early window was ,2.5 times larger than that in the early
time window from Zinzen et al. [25], which we partially attribute
to our use of affinity-purified anti Tin.
The observed prevalence of the GO terms ‘‘mesoderm
development’’ and ‘‘heart development’’ and the prevalence of
genes associated with Tin occupancy with expression patterns in
‘‘trunk mesoderm primordium’’, ‘‘visceral mesoderm primordi-
um’’, and ‘‘cardiac mesoderm primordium’’ (BDGP; [28])
underscores the notion that Tin is bound to a large number of
enhancers that are active in tissues requiring tin. This was further
confirmed by the activity of ,3/4 of our reporter constructs in
various mesodermal domains that overlap with the presence of Tin
protein (although this number may be somewhat skewed because
we purposely omitted Tin-occupied sequences near known non-
mesodermal genes in our analysis). Comparable results were also
reported by the Furlong group [24]–[][26]. Although at first
glance, this could be taken as an indication that Tin is a direct
regulator of most of these tested enhancers and globally-bound
elements, there is an increasing body of evidence suggesting that in
vivo binding of most factors is very promiscuous. According to this
view (e.g., Biggin (2011) [43]), the high concentrations of nuclear
Tin could simply drive binding to sequences containing its cognate
binding motifs, as long as they are accessible as would be the case
in mesodermally-active enhancers. Indeed, several observations
indicate that many Tin-bound sequences do not function as Tin-
dependent enhancers. For example, genes expressed in ectodermal
including neuronal tissues but not in the mesoderm were also very
prevalent globally among the genes linked to Tin-occupancy, and
clearly are not activated by Tin. A prominent example of a gene
with ectodermally-restricted expression associated with Tin-
binding is vnd, which is flanked by one of the most highly Tin-
occupied sequences in the entire genome. Of note, it has been
shown that in mesodermal cells this particular region features the
presence of repressing chromatin marks (H3K27me3) and the
absence of activating marks and of PolII, but contains H3K4me1
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PLOS Genetics | www.plosgenetics.org 12 January 2013 | Volume 9 | Issue 1 | e1003195
which frequently marks potential enhancers [44]. This situation
contrasts with the one found for most enhancers active in the
mesoderm, which tend to show low or absent H3K27me3 but high
activating marks and PolII. One possible interpretation could be
that at the vnd locus, Tin functions in maintaining the repressed
state of a potential enhancer and as a consequence excludes vnd
expression from the mesoderm in order to restrict it to the ventral
ectoderm (perhaps in cooperation or temporal succession with the
Snail repressor [45]). In certain contexts tin does have repressing
functions, particularly during the regulation of Doc within the
dorsal vessel, although the mode of action of Tin in this situation is
not yet known [9], [46]. Likewise, Tin might repress other
ectodermal enhancers in the mesoderm, but genetic evidence for
such a role of tin is currently lacking. An alternative explanation
for Tin binding to vnd sequences would be that it is opportunistic
and does not have any functional consequences. As both Tin and
Vnd belong to the NK homeodomain family and share closely
related binding motifs, Tin may associate neutrally with NK
homeodomain motifs in the mesoderm that are actually destined
for binding of Vnd and vnd autoregulation in the ectoderm, if they
are accessible despite inactivating chromatin marks [47], [48].
Analogous situations could exist at other ectodermal target genes
of vnd and related NK homeobox genes (e.g., Scarecrow [49]). For
a deeper understanding of the genome-wide roles of Tin-
associated sequences it will be necessary to include ectodermally-
expressed genes linked to Tin-binding in functional dissections to
distinguish between neutral and potentially repressive binding.
A significant portion (.20%) of the Tin-bound regions overlap
with so-called HOT regions, which are characterized by the
simultaneous binding of .8 different transcription factors during
pregastrulation stages [27]. It was shown that the vast majority of
HOT regions have enhancer activity, although these do not
necessarily reflect the patterns and stages predicted by the factors
bound to them during blastoderm stages [50]. It is thought that
binding of ubiquitous DNA-binding proteins, particularly the
TAGteam factor Zelda and the GAGA factor (Trithorax-like), to
their binding motifs within HOT regions establishes open
chromatin and that mass action then attracts a variety of other
factors, which in many cases bind neutrally [50]; reviewed in [51].
The observation that many HOT regions can later serve as Tin-
bound mesodermal enhancers may suggest that these enhancers
are ‘‘primed’’ by the binding of chromatin-opening factors to
facilitate binding of mesodermal factors during post-gastrulation
stages. Again, in some cases mesodermal factors including Tin
may bind functionally whereas in other cases they may bind
neutrally. In agreement with this proposal, ,50% of the Tin-
bound mesodermal enhancers from our study overlapped with
HOT regions. Seven among these (tupE9, unc-5L25, malphaL9,
CG3638L6, EgfrE1, eveE428, sliL427) showed cardiac expression
patterns and the others were active in the somatic and/or visceral
mesoderm. In every case among the above HOT regions with
cardiac activities where tested, Tin binding was shown to be
functional.
The sizable yield of cardiac enhancers with functionally
important Tin binding sites is consistent with the known key role
of tin during various stages of cardiac development. In addition, in
light of global data from other factors and the distributions of their
binding motifs [38], [50], our exclusion of regions with low levels
of Tin binding and without well-matching Tin binding motifs
likely selected against regions with promiscuous and neutral Tin
binding. Nevertheless, we did encounter several examples of Tin-
bound mesodermal enhancers that were still active in tin mutant
backgrounds, particularly among those active in the somatic
mesoderm. In some cases shown herein, as well as in the case of
the Fas3L254 enhancer (H.J. and M.F., unpublished), mutations of
the Tin binding motifs did not affect enhancer activity in the
somatic, cardiac, or visceral mesoderm, respectively. We infer that
also at mesodermal enhancers, transcription factors such as Tin
can bind neutrally, for example if a fortuitous binding motif is
made accessible by other factors, including ‘‘chromatin-opening’’
factors or specific histone marks. In other instances, they may be
attracted via mass action solely involving protein-protein interac-
tions, without significantly contributing to the enhancer activity.
Unfortunately, laborious tests are necessary in each case to firmly
distinguish between different scenarios such as, 1) binding that is
biologically essential; 2) binding that makes subtle contributions to
the enhancer activity, which may either be biologically irrelevant
or perhaps affect the robustness of the developmental process; 3)
binding that is functionally redundant with that of other factor(s);
4) promiscuous binding with neutral effects due to the absence of
necessary co-factors; 5) binding that is functionally neutralized by
a co-bound repressor, as has been shown in the case of some
visceral mesoderm enhancers that bind both Tin and the repressor
Sloppy paired (Slp) [26]. More generally, it is becoming apparent
that, in the absence of functional in vivo tests, global binding data
and computational enhancer predictions need to be interpreted
with great caution (as for example discussed in [43], [52], [53]).
Thus, we propose to reserve the terms ‘‘target’’ and ‘‘CRM’’ for
the sequences that have been verified as such in vivo.
In our present study we have performed such tests with a select
number of Tin-bound enhancers active in the cardiogenic
mesoderm and heart and also included the binding motifs of
two other major cardiogenic factors, Pnr and Doc. In five of the six
tested enhancers we could demonstrate that Tin binding is
functional. This result suggests that, at least among enhancers with
cardiac activity, high Tin occupancy, and well-matching Tin
binding motifs, there is a high probability that Tin binding is
functional rather than being promiscuous.
The role of combinatorial occupancy of cardiac
enhancers by cardiogenic factors
Each of the six dissected enhancers showed distinct properties
with regard to its dependency on the binding sites for the different
cardiogenic factors and featured very diverse spatial arrangements
of these sites. Thus, EgfrE1s showed complete dependency on the
Tin sites, but depended on Pnr sites only from stage 13 onwards
and lacked any Doc sites. lin-28L64s required both Tin and Pnr
sites independently, but not the Doc sites. midE19s required both
the Tin and the Doc sites, but not the Pnr sites. RhoLE102s
required the Doc sites but, surprisingly, not the Tin sites and also
not the Pnr sites. tupE9s required only the Tin sites but not the Pnr
and Doc sites. Finally, in unc-5L25s none of the sites of the three
cardiogenic factors were required individually, but in cardioblasts
the presence of either Tin or Doc sites (and, to a lesser degree, Pnr
sites) was essential, which suggests full or partial functional
redundancy between these factors when bound to this enhancer.
In pericardial cells, enhancer activity was retained in the total
absence of binding sites for all three factors, as was the case in
cardiac-specific tin mutants. It is likely that in the wild type, early
tin activates a different set of transcription factors in these
pericardial cells, which in turn activate the unc-5 enhancer.
Altogether, our findings illustrate the diverse functional architec-
ture of each of these cardiac enhancers. At least in part, this
reflects their diverse temporal, spatial, and cell type-specific
activity patterns. Clearly, a lot more effort will be required before
we can fully explain the differential requirement for individual
factors and correlate it with the specific activity patterns of the
respective enhancers.
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In their recent study, Junion et al. [26] assayed global in vivo
binding of Pnr and Doc, as well as the Dpp and Wg signaling
effectors Mad and TCF, and compared their occupancies with
that of Tin. They showed that a significant fraction (,20–40%,
depending on the cut-off) of the Tin-bound regions were co-
occupied by all four of the other factors, which reinforces the
notion that factors are often co-recruited to active enhancers in the
tissues in which they are jointly expressed [43]. An analogous
situation was found for the global occupancies of Nkx2-5, GATA4,
and Tbx5 in a mouse cardiomyocyte cell line and of Nkx2-5,
GATA, and Tbx3 in adult mouse heart, albeit with a lower degree
of overlap as compared to Drosophila [54], [55]. The large majority
of the tested Drosophila enhancers of this type were indeed active in
the dorsal and cardiogenic mesoderm, in which these factors
overlap [26]. While these authors did not examine the function-
ality of individual binding motifs in these enhancers, our present
study suggests that for most enhancers the binding of only one or
two cardiogenic factors among the three (Tin, Pnr, Doc) is
essential and sufficient. Regardless of whether binding is functional
or not, the tendency of co-recruitment of factors to active
enhancers and the knowledge of their domains of spatial overlap
facilitates machine learning approaches to predict spatial patterns
of enhancer activities [25].
Largely based on their analysis of the global frequencies of the
motifs for Tin, Pnr and Doc within the regions binding all five
tested factors versus in those binding only Tin plus one other
factor, Junion et al. [26] proposed that Pnr and Doc are
recruited preferentially to these enhancers to promote the
subsequent recruitment of the other factors including Tin.
Although we agree that examples for such an activity of Pnr and
Doc might exist, the global data may not be sufficiently reliable
to deduct such a general rule. Moreover, the particular enhancer
used to support this model appears to be active exclusively in
ectodermal stripes and not in the mesoderm (which is consistent
with the RNA expression pattern reported for the associated
gene, CG14888; BDGP; [28]). Instead, the initial pan-mesoder-
mal expression of Tin, which occurs prior to the dorsal
mesodermal expression of Pnr and Doc and is needed upstream
of pnr, may argue for the possibility that it is more commonly Tin
rather than Pnr and Doc that functions like a pioneer to promote
the recruitment of subsequent cardiogenic factors. Tin may be
bound to co-repressors prior to the recruitment of subsequent
activators, which could sharpen the on/off state of enhancers
[46], [56]. In the future, these models can be tested via assaying
the in vivo occupancies of cardiogenic factors on binding site-
mutated enhancers or, globally, the occupancies of embryonic
enhancers in purified mesodermal cells from tin, pnr, or Doc
mutant embryos.
The role of the newly discovered CEE motif in cardiac
enhancers
The CEE motif discovered by our machine learning approach
using 24 enhancers with cardiac activities vs. 37 non-cardiac
enhancers was the motif most highly predictive for the cardiac set
of enhancers. The validity of the approach was supported by the
fact that we also found the GATA motif as a classifier for cardiac
enhancers whereas the forkhead domain binding motif was found
as a classifier for somatic mesodermal enhancers. The latter was
also reported in a recent study using a related approach [57]. It
should be noted that the de novo CEE motif is both constructed on
and used for the classification of the same dataset. This can lead to
selection bias that can produce both a high false positive rate in
discovering significant motifs and an overly optimistic estimate of
the classifier performance [58]. Therefore, experimental validation
of de novo motifs prioritized by the machine learning approach is
required to verify their biological function.
In light of these caveats, our findings that three out of eight
tested enhancers require the CEE motifs for normal cardiac
activity do support the conclusion that these motifs correspond to
binding sites of a crucial factor in cardioblasts and their
progenitors. This putative factor likely cooperates with the other
cardiogenic factors that are active at these enhancers. We can not
exclude that this factor is also active when bound to the other
cardiac enhancers that did not depend on its binding sites, where
it may be functionally redundant. Based upon the sequence of the
CEE motif it is difficult to predict the identity of the
corresponding binding factor with confidence. However, we note
that the CEE motif bears a striking similarity with the binding
motifs of several vertebrate Ets domain factors (e.g., FEV, SPI1;
[59]). In Drosophila, the Ets domain factor Pointed (Pnt) has been
identified as an important regulator of heart patterning and the
induction of tin-dependent muscle founder cells in the dorsal
mesoderm [12], [34]. The eve MHE enhancer tested for Pnt
binding does contain CEE motifs, although they were not
included in the mutational analysis by Halfon et al. [12]. The
CEE motif also has some resemblance to activating half sites of
the NFkB factor Dorsal [60], [61], but Dorsal binds to half sites
only poorly, if at all [62], and is present solely in the cytoplasm
with undetectable nuclear levels at the stages when the CEE-
dependent enhancers become active (A. O., unpublished data).
For these reasons, we currently do not favor Dorsal as an essential
CEE-binding trans-activator. Additional studies, including the
determination of the regions bound by Pnt and Dorsal in vivo
during the relevant stages, and genetic as well as biochemical
assays, are needed to clarify whether either Pnt or Dorsal might
correspond to the presumed CEE motif binding factor or whether
another factor is involved. In the near future, the availability of
an increasing number of enhancers active in the cardiac
mesoderm and other mesodermal tissues will greatly improve
the reliability of machine learning approaches to detect novel
functional motifs in tissue-specific enhancers.
Materials and Methods
ChIP–chip
Embryo crosslinking, chromatin isolation, chromatin immuno-
precipitation and DNA amplification were carried out according
to the protocol described previously in detail [38], except that
Protein A/G beads (Pierce) were used for the immunoprecipita-
tion. Wild-type embryo populations were collected at 3–5.5 and 5–
8 hrs after egg laying, respectively. For each developmental time
period, two independent ChIP experiments were performed. The
polyclonal anti-Tin antibody was obtained by affinity purification
with recombinant Tin from rabbit anti-Tin serum [4]. Normal
rabbit IgG was used as the mock control. The final amplified and
labeled DNA samples were hybridized to GeneChip Drosophila
Tiling 1.0R Arrays (Affymetrix) at the microarray core facility of
Mount Sinai School of Medicine (New York, NY). ChIP peaks
were called using Model-based Analysis of Tiling-arrays (MAT)
[63] using a default P-value threshold of 1e-5. The accession
number for the dataset in the Gene Expression Omnibus (GEO)
database is GSE41628. The data were mapped to the UCSC dm3
genome assembly reference genome.
Drosophila strains
The strains M{eGFP.vas-int.Dm}ZH-2A;M{RFP.attP}ZH-51C
and M{eGFP.vas-int.Dm}ZH-2A;M{RFP.attP}ZH-35B [64] were
used for germline transformation of the reporter constructs. The
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strains tin346/TM3,eve-lacZ and tin-ABD;tin346/TM3,eve-lacZ [9]
were used for analyzing the Tin dependency of enhancer activities.
Generation of reporter constructs
Genomic fragments with the coordinates shown in Tables S4
and S5 were amplified from genomic DNA of Oregon R by PCR,
and cloned into either the pH-Stinger-attB vector, which was
constructed by inserting the attB sequence [65] into the AvrII site
of the pH-Stinger vector, and injected into ZH-35B (at Erlangen or
Duke University Model System Genomics, Durham, NC). For
AlkE301, AopE53, AopL18, CG5522E11, EgfrE1, EgfrE63,
gukhE135, meso18EE403, mipleE8, NrtL30, nvyE164, slpE35,
tshL8 and wgnE1197, cloning was done into the eve.promoter-
LacZ-attB vector [66] and injections into ZH-51C (at Rainbow
Transgenic Flies, Inc., Camarillo, CA). Although located closer to
the genes Her and Dot, respectively, the enhancer activities of
HimL47 and oddE81 clearly reflected specific aspects of the
neighboring genes Him and odd and were named accordingly. The
Tin and Doc sites within the genomic fragments were predicted
using the web-based tool Target Explorer [67]. Alignment scores
.4.5 using the same score matrix for Tin as for Tin motif shown
in Figure 1 (see also Table S5) were given higher priority for
selection of candidate enhancer fragments. Mutations of these
motifs and the GATA sequences were obtained via de novo DNA
synthesis (Mr. Gene, Regensburg, DE; Biomatik, Cambridge ON,
CA) (Table S6). For Target Explorer, the position weight matrix
for Tin was built with Tin-binding sites verified experimentally
and in vivo (Table S5) [4], [6], [18], [22], [68]–[][70]. Construction
of the position weight matrices for Doc2 and Mid was based on the
results of SELEX experiments with recombinant Doc2_T-box-
GST and Mid_T-box-GST, which were performed following a
GST pull-down version of the SELEX method described
previously (Table S5) [71].
In situ hybridization
Whole mount embryo in situ hybridization was carried out
following standard protocol, as described previously [69]. The
digoxigenin-labeled probe targeting the eGFP transcript was
synthesized by in vitro transcription of eGFP sequence inserted into
the TOPO cloning site of the pCRII-TOPO vector.
Immunostaining
Immunostaining of embryos using DAB and double or triple
fluorescent immunostaining were carried out as described
previously [69]. The following primary antibodies were used:
rabbit anti-GFP (1:2000, Invitrogen), rabbit anti-b-gal (1:1200,
Promega), rabbit anti-Tin (1:1000, this study), mouse anti-GFP
monoclonal (1:1000, Invitrogen), mouse anti-b-gal monoclonal
(1:50, Developmental Studies Hybridoma Bank), guinea pig anti-
Doc2/3 (1:400) [72], rabbit anti-Eve (1:3000) [73]. For fluorescent
detection, FITC-, Cy3-, or DyLight-conjugated secondary anti-
bodies (Jackson Laboratories) were used. For monoclonal primary
antibodies, Tyramide Signal Amplification (TSA) was performed
using biotinylated secondary antibodies (1:500, Vector Laborato-
ries) in combination with the Vectastain ABC Kit (Vector
Laboratories) and fluorescent Tyramide Reagent (PerkinElmer).
The images of stainings were acquired using the Zeiss ApoTome/
AxioImager.Z1 microscope system with Plan-Apochromat
206/0,8.
De novo motif discovery
We used RSAT tools oligo-analysis and oligo-diff to find
de novo motifs [32]. For both Early and Late datasets we used
oligo-analysis with default parameters on the top 100 peaks. On
the datasets of all peaks we found that with default parameters the
list of de novo motifs is dominated with repeats, thus we use Markov
background model of 3rd order and performed Repeat Masking
[33]. We used default parameters for oligo-analysis and oligo-diff
to discover motifs in subset of experimentally verified enhancers.
We ran RSAT on peak regions defined by MAT, but also on the
full experimentally verified fragments with and without Repeat
Masking. The resulting de novo motifs were curated by hand to
remove duplicates and merge similar motifs (consensus sequences
different in one nucleotide). The CEE motif was derived by
merging a consensus motif enriched in Repeat Masked cardiac
enhancers and a consensus motif discovered by oligo-diff when
comparing cardiac with somatic enhancers. The somatic1 motif
(Figure 6) was discovered as being enriched in somatic enhancers
compared to cardiac using oligo-diff.
Machine learning
We used a classification approach similar to [74]. The set of 61
enhancers was scanned with a database of motifs we derived from:
JASPAR insects collection [75], ChIP-chip for key mesodermal
TFs [25], Dan Pollard’s MEME motifs from FlyReg [76] and de
novo motifs (as described above). We used a log-odds threshold of
4.6 to call significant motif hits with a Markov background of
order 2. A LASSO classifier was trained to predict cardiac
enhancers from the set of 61 experimentally verified enhancers
based on the density of motif hits (defined as number of motif hits
per kb of sequence). Motif hit density was used because the
sequences were of different lengths. The classifier was trained on
1000 bootstrap samples of 61 enhancers and the regularization
parameter picked so to minimize cross-validation error with the
maximal of 50 features selected. We reasoned that if a classifier
picked more than 50 features it would most certainly be over-
fitting the data. The final classifier (Figure 6) was constructed by
taking all features that were present in at least 65% of bootstrap
runs. We picked this threshold by starting with 95% and then
decreasing it as long as the AUC-ROC of the classifier improved.
This yielded a classifier with Area Under the ROC Curve (AUC-
ROC) score of 0.90 obtained from Leave-one-out cross validation
(LOOCV).
Functional analysis of target genes
We assigned each ChIP peak to the nearest gene boundary (59
or 39 exon) from the peak maximal enrichment point in either
direction because a number of key mesodermal enhancers are
known to be downstream of their respective target genes. If the
peak was in an intron, we assigned it to the nearest transcription
start site of the nested gene. We performed GO enrichment
analysis using Ontologizer [77] using the Topology-weight
algorithm to account for the hierarchical structure of GO
ontologies [78]. We used FlyMine to perform protein domain
enrichment analysis [79]. We used the BDGP in situ database
release 3 [28] and we only retained those entries that were marked
of ‘‘acceptable’’ quality. We performed enrichment analysis using
a standard hypergeometic test with False Discovery Rate (FDR)
correction.
Motif location analysis
We analysed motif location (Figure 1) by taking all defined ChIP
regions and scanning them with the appropriate de novo motifs.
Significant motif hits were called above log-odds threshold of 4.5
and their position recorded in percentages relative to peak region
width. Thus, we used the original peak positions without trimming
them to a fixed size. The motif counts were then binned in 5%
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bins and the resulting histogram smoothed using loess smoothing.
We scaled the density so that number 1 represents the expected
uniform distribution. By scanning with unrelated PWMs we
verified that the expected distribution is indeed a flat line at 1 (data
not shown).
Supporting Information
Figure S1 Analysis of peak locations and peak overlaps with
other studies. (A) Peak positions in Tin Early dataset. We assigned
each peak to the target gene as described in Materials and
Methods. A great majority of the peaks fall into introns and
intergenic regions as expected and only a small number into exons.
(B) Peak positions in Tin Late dataset. Although the Late dataset is
considerably smaller, the peak distribution over regions of the
genome is very similar. (C) Venn diagrams of Tin Early and Late
overlap with those from ref. [25]. We overlapped Tin Early and
Late dataset with Zinzen et al. Tin 4–6 h and Tin 6–8 h datasets.
Since the peaks do not always map one-to-one (e.g., one dataset
might call two smaller peaks instead of one larger), the numbers in
overlaps correspond to Tin Early peaks, except for the overlaps
between the Tin Late and Tin 4–6/Tin 6–8 h datasets where the
numbers correspond to Tin Late peaks. The numbers outside the
overlaps are of remaining peaks in each of the dataset. The Tin 4–
6 h dataset is more similar to Tin Early (3–5.5 h), while Tin 6–8 h
dataset is more similar to Tin Late (5–8 h). Furthermore, there is a
core set of 394 overlapping peaks (not shown in the Figure)
between all four datasets. (D) Table of full Tin Early and Late
overlaps with those from ref. [25] and modENCODE HOT
regions with complexity over 8 [27]. Percentages are relative to the
number of peaks of the dataset in table row. Both the Tin Early
and Tin Late dataset, and also the Tin datasets from ref. [25],
show significant overlaps of 36–46% with the HOT regions.
(TIF)
Figure S2 Activity patterns of Tin-bound enhancers in somatic
mesoderm and muscles. Genes are ordered alphabetically, with
CGs last. (A, A9) Expression of commE28-GFP in lateral somatic
mesoderm (A, stage 11) and lateral muscle precursors (A9, stage
14). (B, B9) Expression of fendE160-GFP in all somatic mesoderm
(B, sm, stage 13) and somatic muscles (B9, sm, stage 15), as well as
in lateral ectoderm (ec). (C, C9) Expression of H15L5-GFP in
somatic muscle precursors (C, stage 14) and muscles, as well as in
amnioserosa (C9, stage 15). (D, D9) Expression of hhL2-GFP in
somatic mesoderm (D, stage 10) and muscles ((D9, stage 15). (E, E9)
Expression of lbeL170-GFP in lateral somatic mesodermal cell
clusters encompassing the area around the SBM founder cells and
the lateral adult muscle precursors (E, stage 11; E9, stage 13). (F,
F9) Striped expression of meso18EE403-LacZ in somatic mesoderm
(F, sm, stage 10), residual expression in the somatic mesoderm at
stage 14 (F9, sm), and robust expression in the anterior visceral
mesoderm at stage 14 (F9, vm). (G, G9) Striped expression of
PoxmE138-GFP in the ventral somatic mesoderm (G, stage 11,
ventral view) and in ventral somatic muscles, especially muscles 26,
27, 29 (G9, stage 16). (H, H9) Expression of PscE14-GFP in somatic
mesoderm (H, stage 11) and somatic muscles (H9, stage 16). (I, I9)
Expression of Six4E255-GFP in ventral and lateral somatic
mesoderm (I, stage 11) and ventral/lateral muscle precursors (I9,
stage 14). (J, J9) Expression of slpE35-GFP in segmental stripes in
somatic mesoderm at stage 10 (J, optical section) and stage 11 (J9,
on-view). (K, K9) Expression of zfh1E141-GFP in somatic
mesoderm (K, stage 10) and muscle precursors (K9, stage 13).
(L, L9) Expression of CG5522E11-GFP in somatic mesoderm and
ectodermal stripes (L, stage 10, lateral view; L9, stage 11, ventral
view). (M, M9) Expression of CG10479L38-GFP in somatic muscle
precursors (sm), salivary glands, and endoderm (M, stage 13,
ventral view; M9, stage 14, lateral view). (N, N9) Striped expression
of CG32792E165-GFP in somatic mesoderm (N, stage 11) and in
somatic muscle precursors (N9, stage 14).
(TIF)
Figure S3 Activity patterns of Tin-bound enhancers in trunk
visceral mesoderm and fat body precursors. (A, A9) Expression of
AlkE301-LacZ in visceral mesoderm precursors (A, stage 10,
ventral view) and visceral mesoderm (A9, stage 12, lateral view). (B,
B9) Expression of Fas3L254-GFP in visceral mesoderm precursors
(B, stage 10) and visceral mesoderm (B9, stage 14). (C, C9)
Expression of gukhE135-LacZ in visceral mesoderm (C, stage 12;
C9, stage 15; arrows), as well as in epidermal cells. (D, D9)
Expression of H2.0L95-GFP in trunk visceral muscle founders and
caudal visceral mesoderm (D, stage 12) and in trunk visceral
mesoderm and longitudinal visceral muscle precursors (D9, stage
14). (E, E9) Expression of NrtL30-LacZ in trunk visceral muscle
founders and epidermal stripes (E, stage 11, ventral view), and in
visceral musculature (E9, stage 15). (F, F9) Expression of
wgnE1197-LacZ in mesodermal pair-rule stripes (F, stage 9), and
in visceral musculature of proventriculus and posterior midgut (F9,
stage 16). (G, G9) Expression of oddE81-GFP in fat body primordia
(F, stge 10) and developing lateral fat body (F9, stage 14), an
expression that reflects one aspect of the endogenous odd mRNA
pattern.
(TIF)
Figure S4 Activity patterns of Tin-bound enhancers in tin-
dependent dorsal median cells. (A, A9) Expression of btnE455-GFP
in dorsal median cells (A, stage 11, lateral view; A9, stage 14,
ventral view). (B, B9) Expression of Ten-mE146-GFP in dorsal
median cells and developing head CNS (B, stage 11; B9, stage 15).
(TIF)
Figure S5 Activity patterns of Tin-bound enhancers in non-
mesodermal tissues. (A, A9) Expression of abd-AL104-GFP in
striped ventral ectodermal domains (A, stage 10) and in the
stomatogastric nervous system (A9, stage 16). (B, B9) Expression
of AntpL15-GFP in epidermal areas of the maxillary segment
and in single ectodermally-derived clusters of cells in each
thoracic segment (B, stage 14). At stage 15 (B9), AntpL15-GFP is
present in head areas, maxilla, and the ring gland. (C, C9)
Expression of AopE53-LacZ at stage 13 in most epidermal cells
(C, optical section; C9, superficial view). (D, D9) Expression of
AopL18-LacZ at stage 13 (D) and stage 14 (D9) in epidermal cells
of gnathal segments and in ventrolateral segmental areas of
thoracic and abdominal segments. (E, E9) Expression of
caupL37-GFP in the stomatogastric nervous system (E, stage
15; E9, stage 16). (F, F9) Expression of commE137-GFP largely in
lateral, segmental clusters of ectodermally derived cells (pre-
sumably specific sense organ progenitors; F, stage 12; F9, stage
14). (G, G9) Expression of DiscoL286-GFP in endodermal cells
(presumably corresponding to labial-positive copper cells; G,
stage 14; G9, stage 15). (H, H9) Expression of DrE59-GFP in the
lateral column of neuroectodermal cells (H, stage 10) and in
foregut, hindgut, and salivary gland (H9, stage 15). (I, I9)
Expression of EgfrE63-LacZ in lateral ectodermal cells (I, stage
10) and the roof of the stomodeum (I9, stage 14). (J, J9)
Expression of mipleE8-LacZ in the endoderm (J, stage 12) and in
anterior head tissues (J9, stage 16). (K, K9) Expression of
nvyE164-LacZ in peripheral nervous system progenitors (K,
stage 11) and PNS (K9, stage 15). (L, L9) Uniform epidermal
expression of shgE33-GFP (L, stage 11; L9, stage 14).
(TIF)
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Figure S6 Dependence of the activities of selected Tin-bound
enhancers on tin. Shown are stage 11–12 wild type embryos (A–K)
and homozygous tin346 embryos (A9–K9) carrying the denoted lacZ
or GFP reporter constructs and stained with anti-b-Gal or anti-
GFP (red) and anti-Tin (green). (A) Tin protein and AlkE301-LacZ
co-localize in trunk visceral mesoderm. (A9) In the absence of tin
activity, AlkE301-lacZ is no longer expressed in the trunk visceral
mesoderm. (B) Expression of btnE455-GFP in dorsal median cells
after Tin has become restricted to dorsal mesoderm. (B9) Lack of
btnE455-GFP expression at the normal positions of dorsal median
cells. (C) Co-expression of Fas3L254-GFP with Tin in the trunk
visceral mesoderm. (C9) Severe reduction of Fas3 L254-GFP
expression in the absence of tin activity. (D) Co-expression of
hthE54-GFP with Tin in anterior cardiogenic mesoderm (arrows).
(D9) Lack of hthE54-GFP expression in anterior cardiogenic
mesoderm (arrows). Somatic mesodermal hthE54-GFP is tin-
independent. (E) Expression of lbeL170-GFP in somatic mesoder-
mal clusters after Tin has been restricted to dorsal mesoderm. (E9)
Near lack of lbeL170-GFP expression in the absence of tin activity.
(F) Co-expression of nauL35-GFP and Tin in dorsal somatic
mesoderm clusters. (F9) Lack of nauL35-GFP expression in dorsal
somatic mesoderm in the absence of tin activity. (G) Co-expression
of nocL7-GFP and Tin in cardiogenic mesoderm, and segmented
expression in dorsal somatic mesoderm. (G9) Both cardiogenic and
somatic mesodermal nocL7-GFP depend on tin activity. (H) Co-
expression of NrtL30-LacZ and Tin in the trunk visceral mesoderm
(arrows). (H9) Lack of NrtL30-LacZ activity in trunk visceral
mesoderm in the absence of tin activity. Ectodermal GFP is
unaffected. (I) Six4E255-GFP activity in segmental stripes within
the ventrolateral somatic mesoderm after Tin has been restricted
to the dorsal mesoderm. (I9) Slight reduction of Six4E255-GFP
expression levels in the absence of tin. (J) zfh1E141-GFP expression
in entire mesoderm at the time when Tin has become restricted to
the cardiogenic and parts of the visceral mesoderm. (J9) In the
absence of tin activity there is no significant change in zfh1E141-
GFP activity.
(TIF)
Table S1 Summary of Tin peaks and their gene assignments in
the Tinman Early and Late datasets.
(XLS)
Table S2 GO terms and protein domains enriched in genes
associated with Tin binding peaks. A) GO terms. B) Protein
domains.
(XLS)
Table S3 Enrichment of BDGP in situ hybridization terms. A)
Terms related to Tin expression domains. B) All terms.
(PDF)
Table S4 Integrated tables of Tin binding peaks from 3–5.5 h
(top 455 peaks) and 5–8 h (top 443 peaks) datasets. A) 3–5.5 h
dataset. B) 5–8 h dataset.
(XLS)
Table S5 List of fragments tested in vivo and in machine learning
approach. Summary of all enhancer data, binding motifs present,
and comparison of the in vivo occupancy of these enhancer regions
by various factors tested in Junion et al. (2012) [26].
(XLS)
Table S6 List of mutated sequences.
(XLS)
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